医保计划现在覆盖肥胖症和睡眠性兴奋症,使昂贵的药物更易于获得。 Medicare now covers Zepbound for obesity and sleep apnea, making the costly drug more accessible.

医保计划现在将覆盖Eli Lilly的Zepbound, 治疗肥胖症和中度至严重阻塞性睡眠性脑膜炎患者, 扩大获得昂贵药物的机会。 Medicare will now cover Eli Lilly's Zepbound for patients with obesity and moderate-to-severe obstructive sleep apnea, expanding access to the costly drug. 之前没有被医疗保险或其他许多保险计划所覆盖,Zepbound在12月被FDA批准. Previously not covered by Medicare or many other insurance plans, Zepbound was approved by the FDA in December. 这一决定可以帮助许多由于药物成本高昂而不愿使用该药物的病人。 This decision could help many patients who were hesitant to use the drug due to its high cost.